|
🐜
|
A Probabilistic Functional Network of Yeast Genes
14 auth.
Grzegorz Sumara,
I. Sumara,
I. Rozenberg,
Michael O. Kurrer,
Alexander Akhmedov,
Martin Hersberger,
Urs Eriksson,
F. Eberli,
Burkhard Becher,
J. Borén,
...
M. Cybulsky,
Kathryn J. Moore,
M. Freeman,
Erwin F. Wagner
|
8 |
2004 |
8
🐜
|
|
🐢
|
Postmenopausal hormone-replacement therapy.
K. Martin,
M. Freeman
|
7 |
2001 |
7
🐢
|
|
🐬
|
Surface expression of human CD14 in Chinese hamster ovary fibroblasts imparts macrophage-like responsiveness to bacterial endotoxin.
D. Golenbock,
Yannan Liu,
Frederick H. Millham,
M. Freeman,
Raphael A. Zoeller
|
7 |
1993 |
7
🐬
|
|
🦁
|
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension.
11 auth.
M. Freeman,
Y. Halvorsen,
W. Marshall,
Mackenzie Pater,
J. Isaacsohn,
Catherine Pearce,
...
Brian Murphy,
N. Alp,
Ajay Srivastava,
Deepak L. Bhatt,
Morris J. Brown
|
6 |
2022 |
6
🦁
|
|
🐬
|
Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury
S. Jeyaseelan,
Hong Wei Chu,
S. Young,
M. Freeman,
G. S. Worthen
|
6 |
2005 |
6
🐬
|
|
🐬
|
Spatial Analysis of Almond Leaf Scorch Disease in the San Joaquin Valley of California: Factors Affecting Pathogen Distribution and Spread.
R. L. Groves,
Jianchi Chen,
E. Civerolo,
M. Freeman,
M. Viveros
|
5 |
2005 |
5
🐬
|
|
🦁
|
Results from a phase 1, randomized, double-blind, multiple ascending dose study characterizing the pharmacokinetics and demonstrating the safety and selectivity of the aldosterone synthase inhibitor baxdrostat in healthy volunteers
M. Freeman,
M. Bond,
Brian Murphy,
J. Hui,
J. Isaacsohn
|
5 |
2022 |
5
🦁
|
|
🐢
|
A 96‐week, double‐blind, randomized controlled trial comparing bexagliflozin to glimepiride as an adjunct to metformin for the treatment of type 2 diabetes in adults
7 auth.
Y. Halvorsen,
J. Lock,
J. Frias,
F. Tinahones,
D. Dahl,
Annie L. Conery,
...
M. Freeman
|
4 |
2022 |
4
🐢
|
|
🦁
|
Statins, cholesterol, and the prevention of coronary heart disease
M. Freeman
|
3 |
2006 |
3
🦁
|
|
🐢
|
Bexagliflozin as an adjunct to metformin for the treatment of type 2 diabetes in adults: A 24‐week, randomized, double‐blind, placebo‐controlled trial
Y. Halvorsen,
Annie L. Conery,
J. Lock,
Wenjiong Zhou,
M. Freeman
|
2 |
2023 |
2
🐢
|
